Stock Price
51.50
Daily Change
-0.30 -0.58%
Monthly
2.69%
Yearly
0%
Q2 Forecast
50.16

Recordati reported EUR187.24M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
GlaxoSmithKline GBP 2.12B 558M Mar/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Orion EUR 91.9M 18.8M Mar/2026
Sanofi EUR 2.33B 419M Mar/2026